From September 25th to 28th, the 2025 China Drugstore All Partners Show was grandly held. During the conference, several authoritative industry honor lists were announced, garnering widespread attention. JumpCan Pharmaceutical's Pudilan Xiaoyan Oral Liquid, Xiao'er Chiqiao Qingre Granules (Tonpei), and Jianwei Xiaoshi Oral Liquid were listed in the "2024-2025 China Drugstore Selected Brands" ranking, gaining market recognition with their favorable product reputation and enhancing brand value.

 

 

The China Drugstore Selected Brands Award is characterized by professionalism, effectiveness, and broad recognition. Its winning products represent numerous outstanding products that lead industry trends. Through surveys of frontline pharmacy clerks nationwide and soliciting their opinions, authoritative conclusions were drawn after a strict selection process, ultimately curating a list of medicines belonging to the nation's own from a vast number of pharmaceutical products.

 

Pudilan Xiaoyan Oral Liquid

 

Pudilan Xiaoyan Oral Liquid is meticulously produced by JumpCan Pharmaceutical using modern pharmaceutical technology and imported production equipment through multiple manufacturing processes. Dandelion, Isatis root, and Corydalis are processed using water extraction and alcohol precipitation techniques, while Scutellaria baicalensis undergoes extraction and purification processes to remove impurities and retain the essence for medication. This results in an oral liquid with good absorption, high active ingredient content, and rapid onset of action, making it suitable for both children and adults. Since the beginning of this year, Pudilan Xiaoyan Oral Liquidhas been honored with awards such as the "2024-2025 China Drug Retail Market Bestselling Brand", "Most Popular Star Product in Pharmacies", and the "2025 Healthy China · Brand List", receiving widespread acclaim and becoming a staple in many households. Furthermore, as an approved OTC product, Pudilan Xiaoyan Oral Liquidcan be purchased by patients without a prescription at pharmacies and on e-commerce platforms, making access to medication more convenient.

 

Xiao'er Chiqiao Qingre Granules

 

Xiao'er Chiqiao Qingre Granules (Tongpei) is a specialized pediatric proprietary Chinese medicine. Its formula originates from a classic empirical formula developed by Professor Li Shaochuan, one of China's first nationally recognized senior Traditional Chinese Medicine practitioners, based on over 50 years of medical practice. JumpCan Pharmaceutical inherits and promotes Traditional Chinese Medicine, utilizing modern pharmaceutical technology to allow this renowned formula to benefit more children. Since its launch, Tongpei has won numerous honors, including "Healthy China · Children's Medicine Brand Most Recommended by Parents", "China Drug Retail Market Bestselling Brand", "Most Popular Star Product in Pharmacies", and "Pediatric Brand Most Recognized by Primary Care Doctors." It has consistently ranked on the "Clinical Value Proprietary Chinese Medicine Brands List" and the "China Medicine · Brand List", gaining widespread recognition from doctors, pharmacy staff, and parents, and has become a staple in many household pediatric medicine cabinets.

 

​Jianwei Xiaoshi Oral Liquid

 

JumpCan Pharmaceutical has always adhered to the R&D philosophy of "Leading the Forefront, Innovating Fine Products", committed to continuously providing high-quality medicines for patients. Jianwei Xiaoshi Oral Liquid is an exclusive dosage form developed by the company using patented extraction technology, improving upon the traditional tablet form. The oral liquid dosage form offers better absorption and is more convenient for children and the elderly who may have difficulty chewing, meeting the differentiated medication needs of patients and earning a favorable market reputation.

 

 

​China Drugstore All Partners Show was a comprehensive upgrade in 2023 of the previously successful 22-session China Drugstore Forum, becoming one of the industry's most anticipated annual events. This year's conference, themed "Serve the People", aimed to emphasize the importance of professionalism and attracted thousands of participants. The recognition of JumpCan Pharmaceutical's three products as "2024-2025 China Drugstore Selected Brands" reflects the full affirmation of the market value of these branded products in serving consumers. In the future, JumpCan Pharmaceutical will remain Consumer-Centricity, focusing on the prevention and treatment of diseases, collaborating with pharmacies to conduct professional and academic brand communication, serving the broad consumer base, and continuously earning their deep trust.